Jump to main content
Jump to site search

Issue 1, 2018
Previous Article Next Article

Rise of the biologics


Antibodies, RNA and gene therapy don't necessarily compete with small molecule drugs – and they all rely on chemistry as well.

Graphical abstract: Rise of the biologics

Back to tab navigation

Publication details

The article was received on 15 Nov 2017, accepted on 15 Nov 2017 and first published on 30 Nov 2017

Article type: In the Pipeline
DOI: 10.1039/C7MD90046E
Citation: Med. Chem. Commun., 2018,9, 10-11
  •   Request permissions

    Rise of the biologics

    Med. Chem. Commun., 2018, 9, 10
    DOI: 10.1039/C7MD90046E